AstraZeneca set to buy Alexion for $39 billion
Britain’s AstraZeneca has agreed to buy U.S. drugmaker, Alexion Pharmaceuticals for $39 billion in its largest-ever deal.
Britain’s AstraZeneca has agreed to buy U.S. drugmaker, Alexion Pharmaceuticals for $39 billion in its largest-ever deal.
Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |